Airway Ultrasound Versus Mallampati Score as a Predictor of Difficult Direct Laryngoscopy in Obese Patients

NCT ID: NCT06057818

Last Updated: 2024-02-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-03-01

Study Completion Date

2024-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the ability of pre-operative ultrasound assessment of neck anatomy in predicting difficult laryngoscopy in obese patients undergoing elective surgery requiring tracheal intubation and comparing it to conventional methods as the Mallampati score in anticipating difficult laryngoscopy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All patients enrolled in the study will be consented by written and informed consent to do the airway ultrasound before induction.

During pre-anesthetic evaluation of the patients, demographic variables will be collected from each patient and clinical screening tests to predict difficult airway will be performed in the form of Mallampati score sitting in neutral position.

The patient will be admitted to the pre-anesthesia care unit, attended by anesthesiologist experienced in ultrasound.

The ultrasound will be done with the patients seated, head held in neutral position, using the linear probe 13-6i of SonoSite model M-Turbo c with 13-6Mega Hertz frequency, Preoperative ultrasonographic airway assessment will be performed for all patients in the study, Patients will be explained about the procedure before starting the study.

Operator will position himself on the right side of the patient, holding the ultrasound transducer in the right hand, the transducer will be placed transversely just above the suprasternal notch to visualize the tracheal cartilage, a horseshoe shaped hypoechoic structure, if tracheal deviation is present, the transducer might need to be moved laterally to locate the trachea and its position should be marked out with a pen, the transducer will be moved cephalad to inspect the remaining structures.

The probe will be placed in the transverse axis, ultrasound distances will be measured as the distance from the hyoid bone to skin surface, the distance from skin to anterior commissure of the vocal cords and the distance from skin to the trachea at the level of the suprasternal notch.

All measurements will be done using the ultrasound measure and pointing in mm, gain and depth will be adjusted accordingly to obtain best view.

Difficult intubation tray and settings will be available and ready before induction.

Patients will be taken to the operating room and will be monitored by American Society of Anesthesiologists standard monitors: ECG, noninvasive blood pressure, pulse oximetry, capnography then after pre-oxygenation with fraction of inspired oxygen : 100% for 3 min, intravenous (IV) midazolam 1 mg and fentanyl 1 µg/kg, anesthesia will be induced with injection of propofol 2 mg/kg. After muscle relaxation with injection of rocuronium 0.8 mg/kg IV and ventilation with oxygen and sevoflurane 1.5% for 3 min, direct laryngoscopy will be done by attending anesthesiologist (with more than 2 years of experience post-qualification) using an appropriate size curved Macintosh blade, and the modified Cormack-Lehane (CL) laryngoscopic grade will be evaluated and documented. The correct positioning of the endotracheal tube will be confirmed via capnography and bilateral auscultation of lungs.

The view of the glottis aperture will be assessed using the modified Cormack Lehane scale at which grading of 2b, 3 and 4 will be considered a difficult intubation view for the patient.

The intubating anesthesiologist will not be involved in preoperative clinical and sonographic airway assessment. Therefore, he will be blinded to the findings of preoperative airway evaluation.

Anesthesia will be maintained by sevoflurane, booster doses of rocuronium and fentanyl as needed.

Patients are assessed regarding:

* Mallampati score
* Distance from skin to vocal cords
* Distance from skin to anterior aspect of trachea at level of suprasternal notch
* Distance from skin to hyoid bone

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Airway Ultrasound Difficult Intubation Mallampati Score

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Both sexes
2. Age from18 to 60 years old
3. With an American Society of Anesthesiologists physical status classification score of I to III,
4. Scheduled for elective surgical procedure requiring endotracheal intubation
5. Body mass index more than 30 kg/m2.

Exclusion Criteria

1. Patient refusal
2. Emergency surgery
3. Patients with history of airway or neck surgery
4. Neck mobility abnormalities
5. Syndromatic patients
6. Pre-existing airway malformations or pathology like facial or cervical fractures, maxillofacial abnormalities, cervical tumors or goiter.
7. History of difficult intubation.
8. Patients with tracheostomy tubes.
9. Pregnant patients.
10. Body mass index less than 30 kg/m2.
11. ASA IV or above patients.
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ain Shams University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sherif Hany Adly Loka

assistant lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ain Shams University

Cairo, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sherif HA Loka

Role: CONTACT

00201227671174

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Fatma Ebeid

Role: primary

00201095569596

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MD99/2023

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.